Real-world data of atezolizumab plus carboplatin-etoposide for patients with extensive stage SCLC: The UK experience
Authors
Moliner, L.Woodhouse, Laura
Ahmed, S.
Bhagani, S.
Sevak, P.
Vijay, A.
Steele, N.
Gray, H. L. J.
Robinson, S. D.
Davidson, M.
O'Brien, M. E. R.
Cox, S.
Powell, C.
Khalid, T.
Geldart, T. R.
Hennah, L.
Newsom-Davis, T.
Denton, A.
Blackhall, Fiona H
Califano, Raffaele
Affiliation
Medical Oncology Department, The Christie NHS Foundation Trust, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Moliner L, Woodhouse L, Ahmed S, Bhagani S, Sevak P, Vijay A, et al. Real-world data of atezolizumab plus carboplatin-etoposide for patients with extensive stage SCLC: The UK experience. Annals of Oncology. 2022 Sep;33(7):S1251-S. PubMed PMID: WOS:000866211602093.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.07.1635Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.07.1635Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.07.1635